Free Trial

IGC Pharma (IGC) Earnings Date, Estimates & Call Transcripts

IGC Pharma logo
$0.32 0.00 (-1.24%)
Closing price 05/6/2026 04:10 PM Eastern
Extended Trading
$0.32 0.00 (-0.69%)
As of 05/6/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

IGC Pharma Earnings Summary

IGC Pharma issued Q2 2026 earnings on November 14, 2025, reporting an EPS of -$0.02. Quarterly revenue was reported to be $0.19 million. With a trailing EPS of -$0.07, IGC Pharma's earnings are expected to remain at ($0.08) per share in the coming year.

Actual Revenue
(Nov. 14)
$0.19M

Q2 2026 Earnings Resources

Get IGC Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGC Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IGC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IGC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IGC Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20281-$0.02-$0.02-$0.02
Q2 20281-$0.02-$0.02-$0.02
Q3 20281-$0.02-$0.02-$0.02
Q4 20281-$0.02-$0.02-$0.02

IGC Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/14/2025Q2 2026--$0.02--$0.02-$0.19M
11/12/2024--$0.03-$0.02+$0.01-$0.02$0.29M$0.41M

Data powered by Fiscal.ai.

IGC Pharma Earnings - Frequently Asked Questions

IGC Pharma (NYSEAMERICAN:IGC) last announced its quarterly earning data on Friday, November 14, 2025. Learn more on IGC's earnings history.

The conference call for IGC Pharma's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for IGC Pharma's latest earnings report can be read online.
Read Transcript

IGC Pharma (NYSEAMERICAN:IGC) has a recorded annual revenue of $1.27 million.

IGC Pharma (NYSEAMERICAN:IGC) has a recorded net income of -$7.12 million. IGC has generated -$0.07 earnings per share over the last four quarters.

IGC Pharma's earnings are expected to stay at ($0.08) per share in the next year.


This page (NYSEAMERICAN:IGC) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners